Abiopharma

🔍 Sousa Mauad Bruno (Director)

Company: Aura Minerals Inc. (AUGO)

Report Date: 2026-06-16

Detailed Transactions and Holdings:

• Sold 18,896 shares of Brazilian Depositary Receipts (Derivative)
  Date: 2026-06-17 | Code: J | equity_swap_involved: 0 | shares_owned_after: 16,186,385.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2
• Acquired 18,896 shares of Securities Lending Agreement (Derivative)
  Date: 2026-06-17 | Code: J | equity_swap_involved: 0 | shares_owned_after: 16,243,073.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3, F3, F2
• Sold 10,919 shares of Brazilian Depositary Receipts (Derivative)
  Date: 2026-06-16 | Code: J | equity_swap_involved: 0 | shares_owned_after: 16,210,316.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2
• Acquired 10,919 shares of Securities Lending Agreement (Derivative)
  Date: 2026-06-16 | Code: J | equity_swap_involved: 0 | shares_owned_after: 16,243,073.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3, F3, F2

Footnotes:

• F1: Brazilian Depositary Receipts ("BDR") are certificates representing Common Shares, no par value ("Common Shares") of the Issuer. Three BDRs represent one Common Share of the Issuer.
• F2: The securities are owned directly by entities managed by Kapitalo Investimentos Ltda. ("Kapitalo") and may be deemed to be indirectly beneficially owned by Bruno Sousa Mauad, a partner of Kapitalo.
• F3: Certain clients managed by Kapitalo entered into securities lending agreements whereby title to the securities of the Issuer transferred to a counterparty for the duration of the arrangement. Notwithstanding the foregoing transactions, such clients may be deemed to continues to have beneficial ownership over the securities reported herein as the arragngement may be discontinued at any time by the clients.
• REMARKS: Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.